We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Left Ventricular and Endothelial Function in Preeclampsia

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00201500
First Posted: September 20, 2005
Last Update Posted: August 4, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Central Norway Regional Health Authority
Information provided by (Responsible Party):
Norwegian University of Science and Technology
  Purpose
The purpose of this study is (1) to examine whether the left ventricular function is impaired in women with preeclampsia relative to healthy pregnant controls, (2) to examine whether the endothelial function is impaired in women with preeclampsia relative to healthy pregnant controls, and (3) to examine whether there is a post partum impairment in left ventricular and endothelial function.

Condition Phase
Preeclampsia Phase 1 Phase 2

Study Type: Observational
Study Design: Observational Model: Case Control
Official Title: Left Ventricular and Endothelial Function in Preeclampsia, a Case Control Study

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Left Ventricular Function [ Time Frame: 3 months ]
  • Endothelial Function [ Time Frame: 3 months ]

Biospecimen Retention:   Samples With DNA
Blood samples

Enrollment: 39
Study Start Date: October 2004
Study Completion Date: March 2006
Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)
Groups/Cohorts
preeclampsia
women with preeclampsia
controls
healthy pregnant women

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Women with preeclampsia and women with normotensive pregnancies.
Criteria

Inclusion Criteria:

  • >18 years of age
  • Case: Clinical diagnosis of preeclampsia,
  • Control: Systolic BP <140 mmHg and diastolic BP <90 mmHg

Exclusion Criteria:

  • Known hypertension or other cardiovascular disease
  • Diabetes/gestational diabetes
  • Multiple gestation
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00201500


Locations
Norway
NTNU
Trondheim, Norway, N-7491
Sponsors and Collaborators
Norwegian University of Science and Technology
Central Norway Regional Health Authority
Investigators
Study Chair: Stig A Slørdahl, Professor Norwegian University of Science and Technology
  More Information

Publications:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00201500     History of Changes
Other Study ID Numbers: PEETLV
First Submitted: September 16, 2005
First Posted: September 20, 2005
Last Update Posted: August 4, 2016
Last Verified: August 2016

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications